Morningstar•January 12, 2021Pfizer Inc.: Coronavirus to Create $39 Billion Vaccine Market and $10 Billion Treatment Market in 2021
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
Actions
Download Full ReportRelated Reports
- Analyst Report: Exxon Mobil CorporationFeb 22, 2021 •
XOM
- Weekly Stock ListFeb 22, 2021 •
DD, BHF, TGNA, CTVA, FISV, SNAP, BMY, QSR, HOLX, CMCSA, T, ELAN, ATVI, LH, GE, NLOK, FE, XRX
- Analyst Report: Eli Lilly and CompanyFeb 17, 2021 •
LLY
- Market Update: BMY, COP, KLAC, MDC, TROW, PINSFeb 05, 2021 •
KLAC, TROW, COP, PINS, MDC, BMY
- Analyst Report: Bristol-Myers Squibb Co.Feb 05, 2021 •
BMY
Analyst Profile
Damien Conover, CFA
Sector Director